1. Home
  2. ACMR vs OPT Comparison

ACMR vs OPT Comparison

Compare ACMR & OPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACMR
  • OPT
  • Stock Information
  • Founded
  • ACMR 1998
  • OPT 1984
  • Country
  • ACMR United States
  • OPT Australia
  • Employees
  • ACMR N/A
  • OPT N/A
  • Industry
  • ACMR Industrial Machinery/Components
  • OPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ACMR Technology
  • OPT Health Care
  • Exchange
  • ACMR Nasdaq
  • OPT Nasdaq
  • Market Cap
  • ACMR 932.5M
  • OPT 767.9M
  • IPO Year
  • ACMR 2017
  • OPT 2020
  • Fundamental
  • Price
  • ACMR $15.63
  • OPT $3.27
  • Analyst Decision
  • ACMR Strong Buy
  • OPT Strong Buy
  • Analyst Count
  • ACMR 6
  • OPT 1
  • Target Price
  • ACMR $29.00
  • OPT $12.00
  • AVG Volume (30 Days)
  • ACMR 1.7M
  • OPT 13.2K
  • Earning Date
  • ACMR 11-07-2024
  • OPT 08-30-2024
  • Dividend Yield
  • ACMR N/A
  • OPT N/A
  • EPS Growth
  • ACMR 23.42
  • OPT N/A
  • EPS
  • ACMR 1.33
  • OPT N/A
  • Revenue
  • ACMR $728,968,000.00
  • OPT $261,859.00
  • Revenue This Year
  • ACMR $35.26
  • OPT N/A
  • Revenue Next Year
  • ACMR $21.41
  • OPT $46,864.64
  • P/E Ratio
  • ACMR $11.42
  • OPT N/A
  • Revenue Growth
  • ACMR 46.99
  • OPT N/A
  • 52 Week Low
  • ACMR $13.87
  • OPT $1.79
  • 52 Week High
  • ACMR $34.40
  • OPT $5.45
  • Technical
  • Relative Strength Index (RSI)
  • ACMR 45.80
  • OPT 40.67
  • Support Level
  • ACMR $15.06
  • OPT $3.15
  • Resistance Level
  • ACMR $15.63
  • OPT $3.78
  • Average True Range (ATR)
  • ACMR 0.86
  • OPT 0.18
  • MACD
  • ACMR 0.05
  • OPT -0.00
  • Stochastic Oscillator
  • ACMR 59.47
  • OPT 25.91

About ACMR ACM Research Inc.

ACM Research Inc is a United-based company. It is engaged in developing, manufacturing, and selling single-wafer wet cleaning equipment, which is used by semiconductor manufacturers in numerous manufacturing steps to remove particles, contaminants, and other random defects to improve product yield, in fabricating integrated circuits, or chips. The company offers space alternated phase shift which employs alternating phases of megasonic waves to deliver megasonic energy to flat and patterned wafer surfaces on a microscopic level; and Timely Energized Bubble Oscillation technology which provides effective, damage-free cleaning for both conventional two and three-dimensional patterned wafers at process nodes.

About OPT Opthea Limited

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.

Share on Social Networks: